Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evommune (EVMN) Prepaid Assets (2024 - 2025)

Evommune (EVMN) has disclosed Prepaid Assets for 2 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 119.61% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 119.61% increase, with the full-year FY2025 number at $4.3 million, up 119.61% from a year prior.
  • Prepaid Assets was $4.3 million for Q4 2025 at Evommune, down from $5.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.9 million in Q3 2025 to a low of $1.9 million in Q4 2024.